Wordt geladen...
A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates
We recently reported the clinical results of a Phase I trial combining ipilimumab with a vaccine containing transgenes for prostate-specific antigen (PSA) and for a triad of costimulatory molecules (PROSTVAC) in patients with metastatic castration-resistant prostate cancer. Thirty patients were trea...
Bewaard in:
Gepubliceerd in: | Cancer Immunol Immunother |
---|---|
Hoofdauteurs: | , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Springer Berlin Heidelberg
2014
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6314199/ https://ncbi.nlm.nih.gov/pubmed/24514956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-014-1524-0 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|